Series date: 
12/01/2024 - 8:00am CST to 12/31/2025 - 11:59pm CST

This series is designed for physicians, nurses and nurse practitioners, physician assistants, and other and healthcare professionals and aims to integrate new treatment options for gynecologic cancer patients to reduce hospital readmissions and enhance oncologic outcomes. By comparing National Comprehensive Cancer Network (NCCN) and Levine Cancer Institute (LCI) guidelines with current practices, the program seeks to improve patient outcomes through the incorporation of TNM staging and updated guidelines. Multidisciplinary discussions of recent cases ensure that patients receive the most current, data-driven treatment plans, while also fostering continuous education and evidence-based practice among gynecologic oncologists.

Course Director:

  • Brittany Lees, MD

Overall Objectives:

  1. Integrate new treatment options for gynecologic cancer patients into practice in order to decrease hospital readmissions and improve oncologic outcomes.
  2. Compare NCCN and LCI guidelines for gynecologic cancer patients with current practice in order to improve patient outcomes.
  3. Incorporate TNM staging of gynecologic cancer and guidelines into current practice. 
  4. Evaluate treatment and education regarding cancer diagnoses and treatment options.

Target Audience:  
This activity is designed for physicians and other healthcare professionals.

 

Accreditation Statement

In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement(s)

American Medical Association (AMA) 
Advocate Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Series location: 
Hybrid
Charlotte, NC
United States

Sessions

Session Date
Levine Cancer GYN Tumor Board 2025 - Template 12/01/2024 - 3:30pm to 4:30pm CST
Levine Cancer GYN Tumor Board 2025 - 12/5/2024 12/05/2024 - 3:30pm to 4:30pm CST
Levine Cancer GYN Tumor Board 2025 - 12/12/2024 12/12/2024 - 3:30pm to 4:30pm CST
Levine Cancer GYN Tumor Board 2025 - 12/19/2024 12/19/2024 - 3:30pm to 4:30pm CST
Levine Cancer GYN Tumor Board 2025 01/02/2025 - 3:30pm to 4:30pm CST
Levine Cancer GYN Tumor Board 2025 01/09/2025 - 3:30pm to 4:30pm CST
Levine Cancer GYN Tumor Board 2025 01/16/2025 - 3:30pm to 4:30pm CST
Levine Cancer GYN Tumor Board 2025 01/23/2025 - 3:30pm to 4:30pm CST
Levine Cancer GYN Tumor Board 2025 01/30/2025 - 3:30pm to 4:30pm CST